Showing 1621-1630 of 10610 results for "".
Current and Emerging Roles of Immunotherapy and ADCs for Patients with Non-Muscle-Invasive and Muscle-Invasive Bladder Cancer
https://reachmd.com/programs/cme/current-and-emerging-roles-of-immunotherapy-and-adcs-for-patients-with-non-muscle-invasive-and-muscle-invasive-bladder-cancer/14553/Are you applying the latest data to your practice? Tune in for expert guidance on using ADCs and immunotherapy to treat your patients with mUC.New Treatments in IBD – Professional Webinar Series
https://reachmd.com/programs/cme/new-treatments-in-ibd-professional-webinar-series/15694/Join us for this module of the IBD Pro Webinar Series presentation titled “New Treatments in IBD”. The talk will include new medications, positioning, real world evidence, and the Foundation's EMR IBD Education Tool. The 45 minute presentation will be followed by a 15 minute question and answer sBoard Forum: Managing Overhead
https://reachmd.com/topics/practice-development/board-forum-managing-overhead/35132/Kappa Free Light Chain Index in the Diagnosis of Multiple Sclerosis
https://reachmd.com/diseases-diagnoses/ms-immune-disorders/kappa-free-light-chain-index-in-the-diagnosis-of-multiple-sclerosis/54598/Adoption of the kappa free light chain index can enhance diagnostic accuracy and reduce latency in multiple sclerosis diagnosis, complementing MRI and expert assessment in clinical decision-making.Using a Biologic in a Patient with Atopic Dermatitis and HSV Keratitis
https://reachmd.com/programs/cme/using-a-biologic-in-a-patient-with-atopic-dermatitis-and-hsv-keratitis/11241/Since dupilumab can cause conjunictivitis, is it safe to use in our atopic dermatitis patients with HSV keratitis who have exhausted other options?Options for an Infant with Atopic Dermatitis
https://reachmd.com/programs/cme/options-for-an-infant-with-ad/11242/A mutlidisciplinary panel discusses treatment options for an infant with severe, refractory atopic dermatitis.Emerging Directions in Menin-Directed AML Therapy
https://reachmd.com/programs/cme/emerging-directions-in-menin-directed-aml-therapy/36184/Explore advances in AML that integrate risk stratification, molecular profiling, and menin-targeted therapies to optimize care and improve outcomes.Ongoing Clinical Trials in AML With Menin Inhibitors
https://reachmd.com/programs/cme/ongoing-clinical-trials-in-aml-with-menin-inhibitors/36185/Explore advances in AML that integrate risk stratification, molecular profiling, and menin-targeted therapies to optimize care and improve outcomes.Managing Adverse Events Associated With Menin Inhibitors
https://reachmd.com/programs/cme/managing-adverse-events-associated-with-menin-inhibitors/36182/Explore advances in AML that integrate risk stratification, molecular profiling, and menin-targeted therapies to optimize care and improve outcomes.Applying Evidence to Clinical Practice
https://reachmd.com/programs/cme/applying-evidence-to-clinical-practice/36183/Explore advances in AML that integrate risk stratification, molecular profiling, and menin-targeted therapies to optimize care and improve outcomes.